Literature DB >> 30680580

Dynamics and binding interactions of peptide inhibitors of dengue virus entry.

Diyana Mohd Isa1, Sek Peng Chin1, Wei Lim Chong1, Sharifuddin M Zain1, Noorsaadah Abd Rahman1, Vannajan Sanghiran Lee2.   

Abstract

In this study, we investigate the binding interactions of two synthetic antiviral peptides (DET2 and DET4) on type II dengue virus (DENV2) envelope protein domain III. These two antiviral peptides are designed based on the domain III of the DENV2 envelope protein, which has shown significant inhibition activity in previous studies and can be potentially modified further to be active against all dengue strains. Molecular docking was performed using AutoDock Vina and the best-ranked peptide-domain III complex was further explored using molecular dynamics simulations. Molecular mechanics-Poisson-Boltzmann surface area (MM-PBSA) was used to calculate the relative binding free energies and to locate the key residues of peptide-protein interactions. The predicted binding affinity correlated well with the previous experimental studies. DET4 outperformed DET2 and is oriented within the binding site through favorable vdW and electrostatic interactions. Pairwise residue decomposition analysis has revealed several key residues that contribute to the binding of these peptides. Residues in DET2 interact relatively lesser with the domain III compared to DET4. Dynamic cross-correlation analysis showed that both the DET2 and DET4 trigger different dynamic patterns on the domain III. Correlated motions were seen between the residue pairs of DET4 and the binding site while binding of DET2 results in anti-correlated motion on the binding site. This work showcases the use of computational study in elucidating and explaining the experiment observation on an atomic level.

Entities:  

Keywords:  Antiviral peptides; DENV2; Molecular docking; Molecular dynamics simulations

Mesh:

Substances:

Year:  2019        PMID: 30680580      PMCID: PMC6408556          DOI: 10.1007/s10867-018-9515-6

Source DB:  PubMed          Journal:  J Biol Phys        ISSN: 0092-0606            Impact factor:   1.365


  50 in total

1.  Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate.

Authors:  Y Chen; T Maguire; R E Hileman; J R Fromm; J D Esko; R J Linhardt; R M Marks
Journal:  Nat Med       Date:  1997-08       Impact factor: 53.440

2.  Computational analysis and identification of amino acid sites in dengue E proteins relevant to development of diagnostics and vaccines.

Authors:  Raja Mazumder; Zhang-Zhi Hu; C R Vinayaka; Jose-Luis Sagripanti; Simon D W Frost; Sergei L Kosakovsky Pond; Cathy H Wu
Journal:  Virus Genes       Date:  2007-05-17       Impact factor: 2.332

Review 3.  Cationic peptides: a new source of antibiotics.

Authors:  R E Hancock; R Lehrer
Journal:  Trends Biotechnol       Date:  1998-02       Impact factor: 19.536

4.  Computational identification of self-inhibitory peptides from envelope proteins.

Authors:  Yongtao Xu; Noorsaadah A B D Rahman; Rozana Othman; Peijun Hu; Meilan Huang
Journal:  Proteins       Date:  2012-06-07

5.  Interactions of HIV-1 inhibitory peptide T20 with the gp41 N-HR coiled coil.

Authors:  Kelly Champagne; Akira Shishido; Michael J Root
Journal:  J Biol Chem       Date:  2008-12-10       Impact factor: 5.157

6.  Characterization of the early events in dengue virus cell entry by biochemical assays and single-virus tracking.

Authors:  Hilde M van der Schaar; Michael J Rust; Barry-Lee Waarts; Heidi van der Ende-Metselaar; Richard J Kuhn; Jan Wilschut; Xiaowei Zhuang; Jolanda M Smit
Journal:  J Virol       Date:  2007-08-29       Impact factor: 5.103

7.  Processing and localization of Dengue virus type 2 polyprotein precursor NS3-NS4A-NS4B-NS5.

Authors:  L Zhang; P M Mohan; R Padmanabhan
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

8.  Molecular dynamics simulations on the critical states of the farnesyltransferase enzyme.

Authors:  Sérgio Filipe Sousa; Pedro Alexandrino Fernandes; Maria João Ramos
Journal:  Bioorg Med Chem       Date:  2009-04-02       Impact factor: 3.641

9.  Peptide inhibitors of dengue virus and West Nile virus infectivity.

Authors:  Yancey M Hrobowski; Robert F Garry; Scott F Michael
Journal:  Virol J       Date:  2005-06-01       Impact factor: 4.099

10.  Inhibition of dengue virus entry into target cells using synthetic antiviral peptides.

Authors:  Mohammed Abdelfatah Alhoot; Alwin Kumar Rathinam; Seok Mui Wang; Rishya Manikam; Shamala Devi Sekaran
Journal:  Int J Med Sci       Date:  2013-04-16       Impact factor: 3.738

View more
  6 in total

Review 1.  A review on structural genomics approach applied for drug discovery against three vector-borne viral diseases: Dengue, Chikungunya and Zika.

Authors:  Shobana Sundar; Shanmughavel Piramanayagam; Jeyakumar Natarajan
Journal:  Virus Genes       Date:  2022-04-08       Impact factor: 2.332

2.  A proteomics-MM/PBSA dual approach for the analysis of SARS-CoV-2 main protease substrate peptide specificity.

Authors:  Gloria Gallo; Uilla Barcick; Camila Coelho; Murilo Salardani; Maurício F Camacho; Daniela Cajado-Carvalho; Flávio V Loures; Solange M T Serrano; Leon Hardy; André Zelanis; Martin Würtele
Journal:  Peptides       Date:  2022-05-26       Impact factor: 3.867

3.  In silico binding analysis of lutein and rosmarinic acid against envelope domain III protein of dengue virus.

Authors:  Ritesh Panchal; Sanket Bapat; Sandeepan Mukherjee; Abhay Chowdhary
Journal:  Indian J Pharmacol       Date:  2021 Nov-Dec       Impact factor: 1.200

Review 4.  Updates on Dengue Vaccine and Antiviral: Where Are We Heading?

Authors:  Harun Norshidah; Ramachandran Vignesh; Ngit Shin Lai
Journal:  Molecules       Date:  2021-11-09       Impact factor: 4.411

5.  Peptides targeting dengue viral nonstructural protein 1 inhibit dengue virus production.

Authors:  Pucharee Songprakhon; Thanawat Thaingtamtanha; Thawornchai Limjindaporn; Chunya Puttikhunt; Chatchawan Srisawat; Prasit Luangaram; Thanyaporn Dechtawewat; Chairat Uthaipibull; Sissades Thongsima; Pa-Thai Yenchitsomanus; Prida Malasit; Sansanee Noisakran
Journal:  Sci Rep       Date:  2020-07-31       Impact factor: 4.379

Review 6.  Structure-Based Design of Antivirals against Envelope Glycoprotein of Dengue Virus.

Authors:  Mohd Ishtiaq Anasir; Babu Ramanathan; Chit Laa Poh
Journal:  Viruses       Date:  2020-03-26       Impact factor: 5.048

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.